Selected Publications

Webster, J. A., Luznik, L., Tsai, H. L., Imus, P. H., DeZern, A. E., Pratz, K. W., Levis, M. J., Gojo, I., Showel, M. M., Prince, G., Bolanos-Meade, J., Gondek, L. P., Ghiaur, G., Dalton, W. B., Jain, T., Fuchs, E. J., Gladstone, D. E., Gocke, C. B., Ali, S. A., Huff, C. A., Borrello, I. M., Swinnen, L., Wagner-Johnston, N., Ambinder, R. F., Jones, R. J., Smith, B. D.: Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide. Blood Adv 4(20): 5078-5088, Oct 21 2020.

Deininger, M. W., Shah, N. P., Altman, J. K., Berman, E., Bhatia, R., Bhatnagar, B., DeAngelo, D. J., Gotlib, J., Hobbs, G., Maness, L., Mead, M., Metheny, L., Mohan, S., Moore, J. O., Naqvi, K., Oehler, V., Pallera, A. M., Patnaik, M., Pratz, K., Pusic, I., Rose, M. G., Smith, B. D., Snyder, D. S., Sweet, K. L., Talpaz, M., Thompson, J., Yang, D. T., Gregory, K. M., Sundar, H.: Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 18(10): 1385-1415, Oct 1 2020.

Pollyea, D. A., Pratz, K., Letai, A., Jonas, B. A., Wei, A. H., Pullarkat, V., Konopleva, M., Thirman, M. J., Arellano, M., Becker, P. S., Chyla, B., Hong, W. J., Jiang, Q., Potluri, J., DiNardo, C. D.: Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow-up from a phase 1b study. Am J Hematol Oct 30 2020.

Stein, E. M., DiNardo, C. D., Fathi, A. T., Mims, A. S., Pratz, K. W., Savona, M. R., Stein, A. S., Stone, R. M., Winer, E. S., Seet, C. S., Dohner, H., Pollyea, D. A., McCloskey, J., Odenike, O., Lowenberg, B., Ossenkoppele, G. J., Patel, P. A., Roshal, M., Frattini, M. G., Lersch, F., Franovic, A., Nabhan, S., Fan, B., Choe, S., Wang, H., Wu, B., Hua, L., Almon, C., Cooper, M., Kantarjian, H. M., Tallman, M. S.: Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study. Blood Sept 5 2020.

DiNardo, C. D., Jonas, B. A., Pullarkat, V., Thirman, M. J., Garcia, J. S., Wei, A. H., Konopleva, M., Dohner, H., Letai, A., Fenaux, P., Koller, E., Havelange, V., Leber, B., Esteve, J., Wang, J., Pejsa, V., Hajek, R., Porkka, K., Illes, A., Lavie, D., Lemoli, R. M., Yamamoto, K., Yoon, S. S., Jang, J. H., Yeh, S. P., Turgut, M., Hong, W. J., Zhou, Y., Potluri, J., Pratz, K. W.: Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia. N Engl J Med 383(7): 617-629, Aug 13 2020.

Durand, C. M., Capoferri, A. A., Redd, A. D., Zahurak, M., Rosenbloom, D. I. S., Cash, A., Avery, R. K., Bolanos-Meade, J., Bollard, C. M., Bullen, C. K., Flexner, C., Fuchs, E. J., Gallant, J., Gladstone, D. E., Gocke, C. D., Jones, R. J., Kasamon, Y. L., Lai, J., Levis, M., Luznik, L., Marr, K. A., McHugh, H. L., Mehta Steinke, S., Pham, P., Pohlmeyer, C., Pratz, K., Shoham, S., Wagner-Johnston, N., Xu, D., Siliciano, J. D., Quinn, T. C., Siliciano, R. F., Ambinder, R. F.: Allogeneic bone marrow transplantation with post-transplant cyclophosphamide for patients with HIV and haematological malignancies: a feasibility study. Lancet HIV 7(9): e602-e610, July 7 2020.

Zeidan, A. M., Boddu, P. C., Patnaik, M. M., Bewersdorf, J. P., Stahl, M., Rampal, R. K., Shallis, R., Steensma, D. P., Savona, M. R., Sekeres, M. A., Roboz, G. J., DeAngelo, D. J., Schuh, A. C., Padron, E., Zeidner, J. F., Walter, R. B., Onida, F., Fathi, A., DeZern, A., Hobbs, G., Stein, E. M., Vyas, P., Wei, A. H., Bowen, D. T., Montesinos, P., Griffiths, E. A., Verma, A. K., Keyzner, A., Bar-Natan, M., Navada, S. C., Kremyanskaya, M., Goldberg, A. D., Al-Kali, A., Heaney, M. L., Nazha, A., Salman, H., Luger, S., Pratz, K. W., Konig, H., Komrokji, R., Deininger, M., Cirici, B. X., Bhatt, V. R., Silverman, L. R., Erba, H. P., Fenaux, P., Platzbecker, U., Santini, V., Wang, E. S., Tallman, M. S., Stone, R. M., Mascarenhas, J.: Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts. Lancet Haematol 7(8): e601-e612, June 22 2020.

Freyer, C. W., Carulli, A., Ganetsky, A., Hughes, M. E., Krause, T. M., Timlin, C., Frey, N. V., Gill, S. I., Hexner, E. O., Loren, A. W., Mangan, J. K., Martin, M. E., McCurdy, S. R., Perl, A. E., Pratz, K., Porter, D. L., Luger, S. M.: Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation. Leuk Lymphoma 61(9): 2200-2207, June 3 2020.

Keith W Pratz, Michelle A Rudek, B Douglas Smith, Judith Karp, Ivana Gojo, Amy Dezern, Richard J Jones, Jackie Greer, Christopher Gocke, Maria R Baer, Vu H Duong, Gary Rosner, Marianna Zahurak, John J Wright, Ashkan Emadi, Mark Levis. : A Prospective Study of Peritransplant Sorafenib for Patients With FLT3-ITD Acute Myeloid Leukemia Undergoing Allogeneic Transplantation Biol Blood Marrow Transplant 26(2): 300-306, Feb 26 2020.

Zeidner, J. F., Knaus, H. A., Zeidan, A. M., Blackford, A. L., Montiel-Esparza, R., Hackl, H., Prince, G. T., Gondek, L. P., Ghiaur, G., Showel, M. M., DeZern, A. E., Pratz, K. W., Douglas Smith, B., Levis, M. J., Gore, S., Coombs, C. C., Foster, M. C., Streicher, H., Karp, J. E., Luznik, L., Gojo, I.: Immunomodulation with pomalidomide at early lymphocyte recovery after induction chemotherapy in newly diagnosed AML and high-risk MDS. Leukemia 34(6): 1563-1576, Jan 5 2020.